NRSN logo

NeuroSense Therapeutics (NRSN) Cash From Investing

Annual CFI

$3.65 M
+$7.19 M+202.97%

December 1, 2023

Summary

Performance

1-Year Change

+202.97%

3-Year Change

+40611.11%

5-Year Change

+14123.08%

15-Year Change

+14123.08%

NRSN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.31%
NRSN annual cash flow from investing activities is higher than 73.31% of companies in Healthcare sector

High & Low

All-time High

$3.65 M
NRSN annual cash flow from investing activities is currently at an all-time high

3-Year Low

-$3.54 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NRSN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NRSN next annual earnings announcement has not yet been scheduled

OtherNRSNcash flowmetrics:

Annual CFF

$3.90 M
NRSN annual cash flow from financing activities is $3.90 million

Annual CFO

-$8.45 M
NRSN annual cash flow from operations is -$8.45 million

Annual FCF

-$8.48 M
NRSN annual free cash flow is -$8.48 million

Annual CAPEX

-
NRSN annual capital expenditures value is unknown

Quarterly CFI

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NRSN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.47 M
NRSN quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-$6.05 M
NRSN quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NRSN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NRSN next earnings announcement has not yet been scheduled

OtherNRSNcash flowmetrics:

Quarterly CFF

-
NRSN quarterly cash flow from financing activities value is unknown

Quarterly CFO

-
NRSN quarterly cash flow from operations value is unknown

Quarterly FCF

-
NRSN quarterly free cash flow value is unknown

Quarterly CAPEX

-
NRSN quarterly capital expenditures value is unknown

TTM CFI

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NRSN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.47 M
NRSN TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$6.05 M
NRSN TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NRSN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NRSN next earnings announcement has not yet been scheduled

OtherNRSNcash flowmetrics:

TTM CFF

-
NRSN TTM cash flow from financing activities value is unknown

TTM CFO

-
NRSN TTM cash flow from operations value is unknown

TTM FCF

-
NRSN TTM free cash flow value is unknown

TTM CAPEX

-
NRSN TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NRSN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+203.0%--
3 y3 years+10000.0%--
5 y5 years+10000.0%--

NRSN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+203.0%
5 y5-yearat high+203.0%
alltimeall timeat high+203.0%

NeuroSense Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2024
-
$1000.00(-100.0%)
$1000.00(-100.0%)
Dec 2023
$3.65 M(-203.0%)
-
-
Jun 2023
-
$3.47 M(-157.4%)
$3.47 M(-157.4%)
Dec 2022
-$3.54 M
-
-
DateAnnualQuarterlyTTM
Jun 2022
-
-$6.05 M(>+9900.0%)
-$6.05 M(>+9900.0%)
Dec 2021
-$17.00 K(+88.9%)
-
-
Jun 2021
-
-$2000.00
-$2000.00
Dec 2020
-$9000.00(-65.4%)
-
-
Dec 2019
-$26.00 K
-
-

FAQ

  • What is NeuroSense Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics annual CFI year-on-year change?
  • What is the all time high quarterly CFI for NeuroSense Therapeutics?
  • What is the all time high TTM CFI for NeuroSense Therapeutics?

What is NeuroSense Therapeutics annual cash flow from investing activities?

The current annual CFI of NRSN is $3.65 M

What is the all time high annual CFI for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high annual cash flow from investing activities is $3.65 M

What is NeuroSense Therapeutics annual CFI year-on-year change?

Over the past year, NRSN annual cash flow from investing activities has changed by +$7.19 M (+202.97%)

What is the all time high quarterly CFI for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high quarterly cash flow from investing activities is $3.47 M

What is the all time high TTM CFI for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high TTM cash flow from investing activities is $3.47 M